ThunderBio Innovation

Developer of microfluidic technology for diagnosis and research. The company has developed microfluidic chip (lab on a chip) digital liquid biopsy techniques, for the development and diagnosis of instruments and reagents. The product portfolio includes a digital PCR instrument, Biochip analyzer-droplet reader, droplet generator, constant pressure pump, and reagent kits like digital PCR oil phase composition, digital PCR Kit, nucleic acid extraction kit, thermostatic amplification kit. Founded in The company operates in Life Sciences > Life Sciences Platforms and Tools, Life Sciences > Genomics. Its business models include Genomics > Enabling Technologies > Kits and Reagents > Basic Molecular Biology, Life Sciences Platforms and Tools > Instruments > Diversified. Founded in 2018. Headquartered in China, Jiaxing. The company has raised funding at the Series B stage. Backed by investors including Detong Capital, bftfund.com, Luxin Venture Capital, Zhuopu Investment, Guangzhou Financial Holdings, Daohe Technology Investment, Shenzhen Chenmuyun Technology, BridgeOne Capital, Shanghai Simple Investment Center, the Guangzhou Jinkong.